Literature DB >> 35241568

A Case Treated With Photoimmunotherapy Under a Navigation System for Recurrent Lesions of the Lateral Pterygoid Muscle.

Isaku Okamoto1, Takuro Okada2, Kunihiko Tokashiki2, Kiyoaki Tsukahara2.   

Abstract

BACKGROUND: Head and neck photoimmunotherapy specifically destroys tumor cells by irradiating them with 690 nm red light after administering cetuximab sarotalocan sodium. The key point in the technique of photoimmunotherapy is to set the irradiation area precisely with a margin added to the target lesion while securing a safety zone with large vessels such as the internal carotid artery. CASE REPORT: At our Institution, we performed photoimmunotherapy in combination with use of a navigation system on a male patient in his 70s with maxillary gingival carcinoma who had a recurrent lesion deep in the lateral pterygoid muscle. Three months after photoimmunotherapy, the superficial lesion had disappeared, the area of contrast within the lateral pterygoid muscle had improved, and the patient was deemed to have a complete response.
CONCLUSION: The Navigation System was successfully used in combination with photoimmunotherapy. Additionally, this allowed the location of the internal carotid artery to be confirmed in real time.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Photoimmunotherapy; head and neck carcinoma; maxillary gingival carcinoma.; navigation system

Mesh:

Year:  2022        PMID: 35241568      PMCID: PMC8931901          DOI: 10.21873/invivo.12799

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  10 in total

1.  Direct and abscopal effects of x-radiation on the thymus of the weanling rat.

Authors:  A W LAW; R H MOLE
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1961-05

2.  Adapting Electromagnetic Navigation System for Transoral Robotic-Assisted Skull Base Surgery.

Authors:  Raymond K Tsang; Joseph C K Chung
Journal:  Laryngoscope       Date:  2019-08-01       Impact factor: 3.325

3.  [Intraoperative navigation system in endoscopic sinus surgery].

Authors:  Paweł K Burduk; Krzysztof Dalke; Wojciech Kaźmierczak
Journal:  Otolaryngol Pol       Date:  2012-09

4.  Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors.

Authors:  Tadanobu Nagaya; Jay Friedman; Yasuhiro Maruoka; Fusa Ogata; Shuhei Okuyama; Paul E Clavijo; Peter L Choyke; Clint Allen; Hisataka Kobayashi
Journal:  Cancer Immunol Res       Date:  2019-01-25       Impact factor: 11.151

5.  Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules.

Authors:  Makoto Mitsunaga; Mikako Ogawa; Nobuyuki Kosaka; Lauren T Rosenblum; Peter L Choyke; Hisataka Kobayashi
Journal:  Nat Med       Date:  2011-11-06       Impact factor: 53.440

6.  Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity.

Authors:  Mikako Ogawa; Yusuke Tomita; Yuko Nakamura; Min-Jung Lee; Sunmin Lee; Saori Tomita; Tadanobu Nagaya; Kazuhide Sato; Toyohiko Yamauchi; Hidenao Iwai; Abhishek Kumar; Timothy Haystead; Hari Shroff; Peter L Choyke; Jane B Trepel; Hisataka Kobayashi
Journal:  Oncotarget       Date:  2017-02-07

7.  Photoinduced Ligand Release from a Silicon Phthalocyanine Dye Conjugated with Monoclonal Antibodies: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy.

Authors:  Kazuhide Sato; Kanta Ando; Shuhei Okuyama; Shiho Moriguchi; Tairo Ogura; Shinichiro Totoki; Hirofumi Hanaoka; Tadanobu Nagaya; Ryohei Kokawa; Hideo Takakura; Masayuki Nishimura; Yoshinori Hasegawa; Peter L Choyke; Mikako Ogawa; Hisataka Kobayashi
Journal:  ACS Cent Sci       Date:  2018-11-06       Impact factor: 14.553

8.  Changes in plasma membrane damage inducing cell death after treatment with near-infrared photoimmunotherapy.

Authors:  Kohei Nakajima; Hideo Takakura; Yoichi Shimizu; Mikako Ogawa
Journal:  Cancer Sci       Date:  2018-07-14       Impact factor: 6.716

9.  Near-Infrared Photoimmunotherapy of Cancer.

Authors:  Hisataka Kobayashi; Peter L Choyke
Journal:  Acc Chem Res       Date:  2019-07-23       Impact factor: 22.384

10.  A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma.

Authors:  Makoto Tahara; Susumu Okano; Tomohiro Enokida; Yuri Ueda; Takao Fujisawa; Takeshi Shinozaki; Toshifumi Tomioka; Wataru Okano; Merrill A Biel; Kosuke Ishida; Ryuichi Hayashi
Journal:  Int J Clin Oncol       Date:  2021-06-24       Impact factor: 3.402

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.